Array
(
[id] => 546
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/546.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:02
[updatetime] => 2024-01-11 15:13:02
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => It is not recommended to defer NCS in patients with stage 1 or 2 hypertension. (Evidence: Level C ，Recommendation: Class Ⅲ)
[laiyuan] => 不推荐推迟1期或2期高血压患者的NCS。（证据级别：Level C ；推荐强度：Class Ⅲ）
[znzldj] => A
[_inputtime] => 1704957182
[_updatetime] => 1704957182
[_nrjc] =>
[_nrsh] =>
)
推荐意见
不推荐推迟1期或2期高血压患者的NCS。（证据级别：Level C ；推荐强度：Class Ⅲ）
It is not recommended to defer NCS in patients with stage 1 or 2 hypertension. (Evidence: Level C ，Recommendation: Class Ⅲ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 547
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/547.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:02
[updatetime] => 2024-01-11 15:13:02
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => Pre-operative routine carotid artery imaging is not recommended in patients undergoing NCS. (Evidence: Level C ，Recommendation: Class Ⅲ)
[laiyuan] => 不推荐接受NCS的患者进行术前常规颈动脉成像。（证据级别：Level C ；推荐强度：Class Ⅲ）
[znzldj] => A
[_inputtime] => 1704957182
[_updatetime] => 1704957182
[_nrjc] =>
[_nrsh] =>
)
推荐意见
不推荐接受NCS的患者进行术前常规颈动脉成像。（证据级别：Level C ；推荐强度：Class Ⅲ）
Pre-operative routine carotid artery imaging is not recommended in patients undergoing NCS. (Evidence: Level C ，Recommendation: Class Ⅲ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 548
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/548.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:02
[updatetime] => 2024-01-11 15:13:02
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => Pre-operative carotid artery and cerebral imaging is recommended in patients with a history of TIA or stroke in the previous 6 months and who have not undergone ipsilateral revascularization. (Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 对于在过去6个月内有短暂性脑缺血发作或卒中史且未接受同侧血运重建的患者，推荐进行术前颈动脉和脑成像。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957182
[_updatetime] => 1704957182
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于在过去6个月内有短暂性脑缺血发作或卒中史且未接受同侧血运重建的患者，推荐进行术前颈动脉和脑成像。（证据级别：Level C ；推荐强度：Class Ⅰ）
Pre-operative carotid artery and cerebral imaging is recommended in patients with a history of TIA or stroke in the previous 6 months and who have not undergone ipsilateral revascularization. (Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 549
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/549.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:02
[updatetime] => 2024-01-11 15:13:02
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with known risk factors (age> 65 years, BMI> 30 kg/m2, diabetes, hypertension, hyperlipidaemia, CV disease, or smoking) undergoing intermediate- or high-risk NCS, it is recommended to screen for pre-operative renal disease by measuring serum creatinine and GFR. (Evidence: Level C ，Recommendation: Class Ⅰ)
[laiyuan] => 对于已知有风险因素（年龄 > 65岁、BMI > 30 kg/m2、糖尿病、高血压、高脂血症、心血管疾病或吸烟）且接受中或高风险NCS的患者，推荐通过测量血清肌酐和肾小球滤过率筛查术前肾病。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957182
[_updatetime] => 1704957182
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于已知有风险因素（年龄 > 65岁、BMI > 30 kg/m2、糖尿病、高血压、高脂血症、心血管疾病或吸烟）且接受中或高风险NCS的患者，推荐通过测量血清肌酐和肾小球滤过率筛查术前肾病。（证据级别：Level C ；推荐强度：Class Ⅰ）
In patients with known risk factors (age> 65 years, BMI> 30 kg/m2, diabetes, hypertension, hyperlipidaemia, CV disease, or smoking) undergoing intermediate- or high-risk NCS, it is recommended to screen for pre-operative renal disease by measuring serum creatinine and GFR. (Evidence: Level C ，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 550
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/550.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:02
[updatetime] => 2024-01-11 15:13:02
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients who have known CVD or CV risk factors (including age≥65 years), or symptoms or signs suggestive of CVD it is recommended to obtain a pre-operative 12-lead ECG before intermediate- and high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 对于已知有心血管疾病或心血管危险因素（包括年龄≥65 岁），或有心血管疾病症状或体征的患者，推荐在中高风险NCS术前获取12导联心电图。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957182
[_updatetime] => 1704957182
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于已知有心血管疾病或心血管危险因素（包括年龄≥65 岁），或有心血管疾病症状或体征的患者，推荐在中高风险NCS术前获取12导联心电图。（证据级别：Level C ；推荐强度：Class Ⅰ）
In patients who have known CVD or CV risk factors (including age≥65 years), or symptoms or signs suggestive of CVD it is recommended to obtain a pre-operative 12-lead ECG before intermediate- and high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 551
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/551.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:02
[updatetime] => 2024-01-11 15:13:02
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients who have known CVD, CV risk
factors (including age ≥65 years), or symptoms
suggestive of CVD it is recommended to
measure hs-cTn T or hs-cTn I before
intermediate- and high-risk NCS, and at 24 h and
48 h afterwards.(Evidence: Level B ，Recommendation: Class Ⅰ)
[laiyuan] => 对于已知有心血管疾病或心血管危险因素（包括年龄≥65 岁），或有心血管疾病症状或体征的患者，推荐建议在中高危NCS术前、术后后24小时和48小时测定hs-cTnT或hs-cTnI。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957182
[_updatetime] => 1704957182
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于已知有心血管疾病或心血管危险因素（包括年龄≥65 岁），或有心血管疾病症状或体征的患者，推荐建议在中高危NCS术前、术后后24小时和48小时测定hs-cTnT或hs-cTnI。（证据级别：Level C ；推荐强度：Class Ⅰ）
In patients who have known CVD, CV risk
factors (including age ≥65 years), or symptoms
suggestive of CVD it is recommended to
measure hs-cTn T or hs-cTn I before
intermediate- and high-risk NCS, and at 24 h and
48 h afterwards.(Evidence: Level B ，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 552
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/552.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:02
[updatetime] => 2024-01-11 15:13:02
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients who have known CVD, CV risk factors
(including age ≥65 years), or symptoms suggestive
of CVD, it should be considered to measure BNP
or NT-proBNP before intermediate- and high-risk
NCS. (Evidence: Level B ，Recommendation: Class IIa)
[laiyuan] => 对于已知心血管疾病、心血管危险因素(包括年龄≥65岁)或有心血管疾病症状的患者，应考虑在中高危NCS术前测定BNP或NT-proBNP。（证据级别：Level B ；推荐强度：Class IIa）。
[znzldj] => A
[_inputtime] => 1704957182
[_updatetime] => 1704957182
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于已知心血管疾病、心血管危险因素(包括年龄≥65岁)或有心血管疾病症状的患者，应考虑在中高危NCS术前测定BNP或NT-proBNP。（证据级别：Level B ；推荐强度：Class IIa）。
In patients who have known CVD, CV risk factors
(including age ≥65 years), or symptoms suggestive
of CVD, it should be considered to measure BNP
or NT-proBNP before intermediate- and high-risk
NCS. (Evidence: Level B ，Recommendation: Class IIa)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 553
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/553.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:02
[updatetime] => 2024-01-11 15:13:02
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In low-risk patients undergoing low- and
intermediate-risk NCS, it is not recommended
to routinely obtain pre-operative ECG, hs-cTn T/I,
or BNP/NT-proBNP concentrations.(Evidence: Level B ，Recommendation: Class III)
[laiyuan] => 对于接受低中危风险NCS的患者，不建议常规获取术前心电图、hs-cTn T/I或BNP/NT-proBNP浓度。（证据级别：Level B ；推荐强度：Class III）
[znzldj] => A
[_inputtime] => 1704957182
[_updatetime] => 1704957182
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于接受低中危风险NCS的患者，不建议常规获取术前心电图、hs-cTn T/I或BNP/NT-proBNP浓度。（证据级别：Level B ；推荐强度：Class III）
In low-risk patients undergoing low- and
intermediate-risk NCS, it is not recommended
to routinely obtain pre-operative ECG, hs-cTn T/I,
or BNP/NT-proBNP concentrations.(Evidence: Level B ，Recommendation: Class III)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 554
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/554.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:02
[updatetime] => 2024-01-11 15:13:02
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => TTE is recommended in patients with poor
functional capacityc and/or high NT-proBNP/
BNP,d or if murmurs are detected before high-risk
NCS, in order to undertake risk-reduction
strategies. (Evidence: Level B ，Recommendation: Class I)
[laiyuan] => 对于功能能力差和/或NT-proBNP/BNP高或在高危NCS术前检测到杂音的患者，推荐使用经胸超声心电图，以便采取降低风险的策略。（证据级别：Level B ；推荐强度：Class I）。
[znzldj] => A
[_inputtime] => 1704957182
[_updatetime] => 1704957182
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于功能能力差和/或NT-proBNP/BNP高或在高危NCS术前检测到杂音的患者，推荐使用经胸超声心电图，以便采取降低风险的策略。（证据级别：Level B ；推荐强度：Class I）。
TTE is recommended in patients with poor
functional capacityc and/or high NT-proBNP/
BNP,d or if murmurs are detected before high-risk
NCS, in order to undertake risk-reduction
strategies. (Evidence: Level B ，Recommendation: Class I)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 555
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/555.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:02
[updatetime] => 2024-01-11 15:13:02
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => TTE should be considered in patients with suspected new CVD or unexplained signs or symptoms before high-risk NCS.(Evidence: Level B ，Recommendation:Class IIa)
[laiyuan] => 疑似新发的心血管疾病或在高危NCS之前有不明原因的体征或症状的患者，应考虑经胸超声心电图。（证据级别：Level B ；推荐强度：Class IIa）
[znzldj] => A
[_inputtime] => 1704957182
[_updatetime] => 1704957182
[_nrjc] =>
[_nrsh] =>
)
推荐意见
疑似新发的心血管疾病或在高危NCS之前有不明原因的体征或症状的患者，应考虑经胸超声心电图。（证据级别：Level B ；推荐强度：Class IIa）
TTE should be considered in patients with suspected new CVD or unexplained signs or symptoms before high-risk NCS.(Evidence: Level B ，Recommendation:Class IIa)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
